# EHR-Bench — prescriptions — qid=ehr_bench_decision_making_9023
**gold:** `['Potassium Chloride']`

- Agentic F1 = **0.00** · final answer: `['Micro-K']`
- One-shot F1 = **1.00** · final answer: `['Potassium Chloride']`

**Why:** Agentic ran 22 tool calls and still arrived at `['Micro-K']`; one-shot answered `['Potassium Chloride']` directly. The extra rounds appear to have introduced noise or second-guessing rather than improving the answer.

---
### Agentic prompt (2926 chars)

```
<task_instruction>
Please give the next Prescriptions suggestion for the patiens.

Analyze the patient's EHR records up to the current time to make your prediction.
Do not assume any unseen future events beyond the current time.
When you need medical knowledge or clinical information, use the `browser.search` tool to find authoritative medical information from reliable sources.
Submit your final answer through `ehr.finish`. Your answer must be chosen only from the candidate list below.
</task_instruction>

<patient_info>
Current Time: 2152-11-22 19:46:08
Patient Subject ID: 19127408
</patient_info>

<candidate_answers>
["Potassium Chloride (Powder)", "Insulin (Regular) for Hyperkalemia", "Caltrate", "Klor-Con 8", "Potassium Acetate", "Copper Chloride", "Potassium Chloride (Klor-conM10)", "Potassium Phosphate", "Sodium Chloride 23.4%", "Potassium Chl 40 mEq / 1000 mL D5NS", "KePPRA", "Kcentra*", "Potassium Chloride", "Potassium Chloride (Po 20mEq PKT", "magnesium chloride", "potassium citrate", "Potassium Chl 20 mEq / 1000 mL D5W", "Sodium Chloride  (Mini Bag Plus)", "Potassium Chl 40 mEq / 1000 mL NS", "Sodium Chloride 5 %", "Iso-Osmotic Sodium Chloride", "Potassium Ch", "Klor-Con", "Alum Potassium", "Micro-K", "Potassium Chloride Oral Sol", "sodium chlor", "Zinc Chloride", "Sodium Chloride", "urea", "Saline", "Phosphorus", "Urea", "ethyl chloride", "Calcium Gluconate", "Polyethylene Glycol", "KlonoPIN", "Potassium Chl 20 mEq / 1000 mL NS", "potassium citrate ER", "23.4% Sodium Chloride", "Ket", "Potassium Chl 20 mEq / 1000 mL D5NS", "0.9% Sodium Chloride", "Ethyl Chloride", "potassium ch", "potassium gluconate", "aluminum chloride", "Chlorthali", "Klor-Con 10", "Klonopin", "Potassium Iodide", "Sodium", "sodium bicarb-sodium chloride", "Keflex", "Potassium Chloride Oral Soln", "Keppra", "potassium", "Potassium Chl 20 mEq / 1000 mL D5LR", "0.9 % Sodium Chloride", "Potassium Chl 40 mEq / 1000 mL D5W", "Calcium Chloride", "keppra", "Potassium Citrate", "Potassium Chloride 10meq Capsules", "Hydrochloric Acid", "0.83% Sodium Chloride", "potassium chloride ER", "Sodium Chloride 7%", "Potassium Chloride Replacement (Oncology)", "Mineral", "calcium gluconate", "Sodium Phosphate", "Ketorola", "Chloral hydrate", "PlasmaLyte", "potassium chloride", "potassium citrate tablets", "Balanced Salt Opth. Soln", "Potassium Chloride Replacement (Critical Care and Oncology)", "sodium chloride", "Potassium Bicarbonate Eff", "Potassium Chloride 10mEq TAB", "Solution", "Sodium Chloride 0.9% (P.F.)", "Potassium Chl 20 mEq / 1000 mL D5 1/2 NS", "Potassium Chl 40 mEq / 1000 mL D5 1/2 NS", "Potassium C 20mEq/50mL 50mL IVPB", "chlorh", "Keppra *Brand Name*", "Creatinine (Bulk)", "Potassium 10mEq/100mL 100mL IVPB", "Potassium", "chloral hydrate", "Kcentra", "Isotonic Sodium Chloride", "Urocit-K 10", "sodium", "potassium chlo", "Keppra BRAND NAME", "Potassium Chl", "Chloral Hydrate"]
</candidate_answers>
```

### Agentic tool-call sequence (22 calls)

ehr.load_ehr, ehr.get_table_names, ehr.think, ehr.get_records_by_time, ehr.get_records_by_time, ehr.get_latest_records, ehr.run_sql_query, ehr.run_sql_query, ehr.get_column_names, ehr.run_sql_query, ehr.run_sql_query, ehr.get_records_by_time, browser.search, browser.open, browser.open, browser.search, ehr.think, ehr.get_records_by_time, ehr.get_records_by_time, ehr.run_sql_query, ehr.run_sql_query, ehr.finish

### Agentic final assistant reasoning

> Based on my comprehensive analysis:
> 
> **Clinical Summary:**
> - Patient has heart failure, atrial fibrillation, pneumonia, and CKD
> - Receiving IV Furosemide (loop diuretic) - causes potassium loss
> - Recent potassium level: 3.9 mEq/L (lower end of normal 3.3-5.1)
> - Patient is on ongoing potassium replacement therapy
> - Multiple active prescriptions for Potassium Chloride (MicroK10) are current
> 
> **Prescription Pattern:**
> The patient has been consistently prescribed Potassium Chloride (MICROK10 - 10mEq ER Tablets) multiple times per day. The most recent prescription was at 11:00 on 11/22 for 20mEq (2…

---
### One-shot prompt (29122 chars)

```
<task_instruction>
Given the sequence of events that have occurred in a hospital, please give the next Prescriptions suggestion for the patiens.
All patient events needed for this task are already included below.
The current time is 2152-11-22 19:46:08, which is exactly one second after the latest observed event at 2152-11-22 19:46:07.
Use only the provided patient timeline.
Do not assume any unseen future events beyond the current time.
No EHR database lookup is needed for this record because the full timeline is embedded in the prompt.
Return only the final answer text. If multiple answers are needed, put one answer per line with no bullets or numbering. If candidate answers are provided, choose only from that candidate list.
</task_instruction>

<patient_info>
Current Time: 2152-11-22 19:46:08
</patient_info>

<patient_timeline>
## Patient Demographics [None]
- Anchor_Age: 48
- Gender: F

## Discharge [2152-11-09 00:00:00]
- Note_Type: DS
- Text:  
Name:  ___            Unit No:   ___
 
Admission Date:  ___              Discharge Date:   ___
 
Date of Birth:  ___             Sex:   F
 
Service: MEDICINE
 
Allergies: 
No Known Allergies / Adverse Drug Reactions
 
Attending: ___.
 
Chief Complaint:
Shortness of breath

 
Major Surgical or Invasive Procedure:
None

 
History of Present Illness:
Ms. ___ is a ___ year old woman with morbid obesity,
hypertrophic cardiomyopathy, OSA using 2L at night, Afib on
rivaroxaban, and recent admission ___ for volume overload, 
who
presents with shortness of breath and lower extremity swelling.

The patient shares that over the past two months she has had
worsening shortness of breath and lower extremity swelling. She
notes the lower extremity swelling actually started about nine
months ago in ___, which prompted an admission for
volume overload. She was again hospitalized ___ for leg/foot
pain. The pain was thought to be from either volume overload,
neuropathic pain, or a combination of both.  and she said she
felt better at discharge. However, within a few weeks of
discharge her symptoms returned. The edema in her legs is so
severe that she experiences blistering as a result. Her 
shortness
of breath has also worsened, and she has been using her home O2
(normally uses when she sleeps for her OSA) more frequently. The
shortness of breath does worsen with exertion, and there is no
associated chest pain. She has had a cough for about two weeks,
productive of green and clear mucous. Her cough and breathing
have been exacerbated by her boyfriend smoking marijuana and
cigarettes in her bedroom. Per chart review, she has not been
feeling well since her admission ___.

In the ED initial vitals were: 98.1 97 110/pulse 22 96% 2L NC.
Exam was notable for morbid obesity, expiratory wheezing, 2+
lower extremity edema to mid shin with tender small blistering.
Her labs were notable for WBC 17, Hb 9.9, BNP ___, Cr 1.1, Trop
0.03. Negative UA. EKG showed LBBB (baseline). CXR showed stable
cardiomegaly, with no acute edema. Cardiology was consulted, and
recommended admission for diuresis. She was given Lasix 80 mg 
IV,
fioricet, oxycodone, ipratropium nebulizer. 

On the floor the patient reports continued cough, chills, and
dyspnea. She feels a little bit better since the ED. She has 
been
incontinent of urine and reports a rash in her groin.

 
Past Medical History:
 Hypertrophic cardiomyopathy (LVH (2.6/1.5), LVEF >75%, LVOTO 
25-->98 mmHg, nl valves.)  
 Paroxysmal Afib  
 Hypertension  
 Morbid Obesity  
 GERD  
 OSA not on CPAP  
 Cholelithiasis  
 Depression  
 Impaired glucose tolerance  
 Colon polyps  
 CKD  
 Asthma  

 
Social History:
___
Family History:
Father: Died of MI at ___ 
Brother: MI at ___- s/p 3 vessel CABG at ___; SLE.  
Mother: colon cancer, died while on dialysis, asymmetric septal 
hypertrophy 
Son: CAD; s/p stent placement age ___
 
Physical Exam:
PHYSICAL EXAMINATION:  
=====================
VITALS:  101.0 PO 139 / 80 92 22 96% 4L  
GENERAL: Morbidly obese lying in bed, appears quite 
uncomfortable
HEENT: NCAT. Sclera anicteric. MMM 
NECK: Unable to appreciate JVD due to habitus 
CARDIAC: irregularly irregular. 
LUNGS: Unable to examine posteriorly but anteriorly decent air
movement with expiratory wheezing throughout 
ABDOMEN: Soft, NTND. No HSM or tenderness.  
EXTREMITIES: b/l 1+ pitting edema w/ venous stasis changes
SKIN: +stasis dermatitis, with blistering

DISCHARGE EXAMINATION
=====================
Vitals: 97.5 PO 108/68 BP 98HR  20 RR 93 % RA
GENERAL: BMI ___, lying in bed, coughing mildly throughout exam, 
no acute distress
HEENT: hirsutism, EOMI, PEERLA
NECK: JVD elevated 10 cm
CARDIAC: regular rhythm, normal rate, no M/R/G
LUNGS: Good air movement bilaterally but with shallow breaths. 
Bibasilar crackles improved. Ongoing expiratory wheezes. 
ABDOMEN: Soft, obese, NTND. No HSM or tenderness.  
EXTREMITIES: bilateral 1+ pitting edema to approximately 2 
inches below knee w/ venous stasis changes, improving from prior 
; right lateral thigh - TTP but no bruising , erythema 
SKIN: +stasis dermatitis, with blistering
 
Pertinent Results:
Labs on Admission
=================
___ 11:21PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG 
GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-7.0 
LEUK-NEG
___ 11:21PM URINE  COLOR-Straw APPEAR-Clear SP ___
___ 11:21PM   ___ PTT-25.4 ___
___ 11:21PM   PLT COUNT-376
___ 11:21PM   NEUTS-77.4* LYMPHS-14.4* MONOS-6.9 EOS-0.6* 
BASOS-0.2 IM ___ AbsNeut-13.19* AbsLymp-2.46 AbsMono-1.17* 
AbsEos-0.10 AbsBaso-0.03
___ 11:21PM   WBC-17.0*# RBC-4.10 HGB-9.9* HCT-32.8* 
MCV-80* MCH-24.1* MCHC-30.2* RDW-16.8* RDWSD-47.9*
___ 11:21PM   CALCIUM-11.3* PHOSPHATE-4.0 MAGNESIUM-1.9
___ 11:21PM   proBNP-___*
___ 11:21PM   GLUCOSE-137* UREA N-20 CREAT-1.1 SODIUM-145 
POTASSIUM-3.8 CHLORIDE-96 TOTAL CO2-32 ANION GAP-17*
___ 01:36AM   cTropnT-0.03*
___ 06:05AM   CK-MB-1 cTropnT-0.03*
___ 06:05AM   ALT(SGPT)-10 AST(SGOT)-12 LD(___)-238 ALK 
PHOS-99 TOT BILI-0.6

Pertinent Labs
==============
___ 08:05AM BLOOD Glucose-269* UreaN-34* Creat-1.6* Na-142 
K-4.2 Cl-95* HCO3-32 AnGap-15
___ 11:21PM BLOOD proBNP-___*
___ 01:36AM BLOOD cTropnT-0.03*
___ 06:05AM BLOOD CK-MB-1 cTropnT-0.03*

Microbiology
============
___ SPUTUM GRAM STAIN-FINAL; RESPIRATORY 
CULTURE-FINAL INPATIENT 
___ SPUTUM GRAM STAIN-FINAL; RESPIRATORY 
CULTURE-FINAL INPATIENT 
___ BLOOD CULTURE Blood Culture, Routine-FINAL 
INPATIENT 
___ BLOOD CULTURE Blood Culture, Routine-FINAL 
INPATIENT 
___ URINE URINE CULTURE-FINAL EMERGENCY WARD 
___ 06:05AM BLOOD ALT-10 AST-12 LD(___)-238 AlkPhos-99 
TotBili-0.6

Discharge Labs
==============
___ 09:02AM BLOOD WBC-13.5* RBC-4.25 Hgb-10.2* Hct-34.9 
MCV-82 MCH-24.0* MCHC-29.2* RDW-17.2* RDWSD-51.4* Plt ___
___ 09:02AM BLOOD Glucose-203* UreaN-32* Creat-1.4* Na-141 
K-4.3 Cl-93* HCO3-32 AnGap-16
___ 09:02AM BLOOD Calcium-9.1 Phos-3.4 Mg-2.6

Imaging
=======
CXR: Stable moderate to severe cardiomegaly.  No evidence of 
pulmonary vascular congestion or pulmonary edema. 

TTE:
LEFT ATRIUM: Elongated LA. 

RIGHT ATRIUM/INTERATRIAL SEPTUM: Moderately dilated RA. Normal 
IVC diameter (<=2.1cm) with <50% decrease with sniff (estimated 
RA pressure ___ mmHg). 

LEFT VENTRICLE: Asymmetric LVH. Normal LV cavity size. 
Suboptimal technical quality, a focal LV wall motion abnormality 
cannot be fully excluded. Overall normal LVEF (>55%). TDI E/e' 
>13, suggesting PCWP>18mmHg. No resting LVOT gradient. 

RIGHT VENTRICLE: Normal RV chamber size and free wall motion. 

AORTA: Normal aortic diameter at the sinus level. Mildly dilated 
ascending aorta. 

AORTIC VALVE: Normal aortic valve leaflets (?#). No AS. No AR. 

MITRAL VALVE: Normal mitral valve leaflets. No MVP. Moderate 
mitral annular calcification. No ___ of mitral valve leaflets. 
Mild (1+) MR. 

___ VALVE: Normal tricuspid valve leaflets with trivial 
TR. Borderline PA systolic hypertension. 

PERICARDIUM: Trivial/physiologic pericardial effusion. 

GENERAL COMMENTS: Suboptimal image quality - poor echo windows. 
Suboptimal image quality as the patient was difficult to 
position. Suboptimal image quality - body habitus. Suboptimal 
image quality - patient unable to cooperate.   

Conclusions   
The left atrium is elongated. The right atrium is moderately 
dilated. The estimated right atrial pressure is ___ mmHg. There 
is marked asymmetric septal hypertrophy with normal cavity 
size.. Due to suboptimal technical quality, a focal wall motion 
abnormality cannot be fully excluded. Overall left ventricular 
systolic function is normal (LVEF>55%). No valvular ___ or 
resting LVOT gradient is seen. Tissue Doppler imaging suggests 
an increased left ventricular filling pressure (PCWP>18mmHg). 
Right ventricular chamber size and free wall motion are normal. 
The ascending aorta is mildly dilated. The aortic valve leaflets 
(?#) appear structurally normal with good leaflet excursion. 
There is no aortic valve stenosis. No aortic regurgitation is 
seen. The mitral valve leaflets are structurally normal. There 
is no mitral valve prolapse. Mild (1+) mitral regurgitation is 
seen. There is borderline pulmonary artery systolic 
hypertension. There is a trivial/physiologic pericardial 
effusion. 

IMPRESSION: Suboptimal image quality. Asymmetric septal 
hypertrophy with preserved global biventricular systolic 
function. Mild mitral regurgitation. Borderline PA systolic 
hypertension. Mildly dilated ascending aorta. Increased PCWP. 

 
Brief Hospital Course:
___ year old woman with BMI 61, hypertrophic cardiomyopathy, OSA 
on home 2L, Afib (on rivaroxaban, metoprolol, amiodarone), and 
recent admission ___ for volume overload, who was admitted 
from ___ to ___ for respiratory symptoms concerning for 
atypical PNA and CHF exacerbation. 
=
=
=
=
=
=
================================================================
ACUTE ISSUES

#Shortness of breath 
#Fevers / Cough 
#Leukocytosis 
#Hypoxia
Patient presented with leukocytosis, cough with profuse 
mucus/hemoptysis, and fever to 101 with history of chills and 
sputum. Her CXR had evidence of PNA. Her cough and SOB with e/o 
reactive airway disease was c/f atypical PNA. She was treated 
with Ceftriaxone (___), Azithromycin (___), 
steroid burst (___), cough suppressants, decongestants, 
Tylenol, and NC oxygen. Her prior PFT's showed no convincing 
obstructive pattern to suggest comorbid COPD, although she has a 
reported history of asthma. She had diffuse wheezes that were 
treated with atrovent / albuterol. She had an admission Wells 
score of 3 as she had hemoptysis temporarily during initial days 
of admission, but PE was considered less likely given O2 sat 
100% on 2L NC and the fact that she was on rivaroxaban prior to 
presentation. On discharge, she had a persistent mild cough with 
nonbloody mucus and persistent mild leukocytosis (which appears 
to be semi-chronic). Acute exacerbation of HFpEF also 
contributed to SOB as noted below.

#Lower extremity swelling 
#Acute on chronic HFpEF: LVEF >=55%, Dry weight 302lb ___, 
new dry weight likely between 107 and 112lbs
#HOCM 
Patient presented volume overloaded ISO known HFpEF, and her 
admission BNP was elevated at 2076 with a standing weight of 315 
lbs. Her Troponins were 0.03x2. She reports difficulty with 
volume control at home. Her TTE showed some evidence of right 
heart strain with borderline PA systolic hypertension and 
increased PCWP. She was diuresed with IV Lasix 160mg boluses 
typically BID, judiciously ISO HOCM. Exam improved with 
diuresis, with discharge weight was 312 lbs (still has some mild 
overload, would suspect true dry weight is somewhere between 307 
and 312lbs). She was transitioned back to home PO torsemide 
prior to discharge, with stable weight, and discharged on PO 
torsemide 100mg daily. 

___ L>R Pain
She had persistent burning pain on her feet that was consistent 
with prior presentation for ___ pain ___ ___ swelling. She does 
not have known DM, and the character of her pain was not c/f 
radiculopathy though she has felt this in the past. The pain, 
especially on her left leg, persisted after diuresis. Her pain 
improved with lidocaine ointment, capsaicin, gabapentin 400 mg 
TID, standing acetaminophen 1g TID, and diuresis. 

#Afib
She was rate (fractionated metoprolol) and rhythm controlled 
(home amiodarone), and was in and out of sinus by telemetry. Her 
CHA2DS2-VASc score = 3. Her rivaroxaban was continued. 

#Depression/PTSD
#Steroid psychosis
#Group B personality d/o
She was frequently tearful, depressed d/t multiple social 
stressors at home but was without active suicidal ideation. She 
reported some visual hallucinations and agitation ISO steroid 
burst, which improved following cessation of steroids. She was 
titrated on a regimen to help with her sleep/mood symptoms 
(ramelteon, trazodone, and seroquel). 

#Anemia
She has iron deficiency (based on prior labs). Hct stable this 
admission. 

#OSA 
Continued on home 2L @ night intermittently. 

#GERD 
#Chronic inactive gastritis
Patient was on home pantoprazole and ranitidine. Her dexilant 
was held as it was not in the formulary. 

#Morbid obesity
#Hyperglycemia
Sugars were high 100s - low 200s. Last A1c in ___: 6.1% 

#Yeast dermatitis. 
She had erythematous fold without skin breaks under her pannus, 
in her bilateral groin area, and under her breasts. She was 
started on nystatin and then miconazole powder, given the 
persistence of her erythema.

#HLD
Her home atorvastatin 40 mg qPM was continued.

#Hypercalcemia 
Isolated 11.3 on admission, 8.9 and 8.1 on repeat ISO aggressive 
diuresis

TRANSITIONAL ISSUES
===================
DISCHARGE WEIGHT: 312lb
DISCHARGE DIURETIC: Torsemide 100mg daily

- PCP follow up:
1) Titration of her medications for ___ pain secondary to 
swelling/neuropathy
2) Evaluation of mood symptoms, insomnia
3) Repeat A1c as random glucose levels >200
4) Consider repeat PFTs ISO clinical e/o reactive airway disease 
(picture clouded by likely atypical PNA)
5) Evaluate erythematous skin improvement on miconazole powder; 
patient told to utilize gentle washing to help
6) Consider referral to Surgical outpatient to remove skin tags
7) Repeat Colonoscopy (reports she was due in ___ 
8) Please consider a repeat Fe, when she is no longer in an 
inflammatory phase
9) Please consider a repeat Calcium and appropriate further 
workup, as had an isolated elevated calcium value on admission

- Cardiology follow up:
1) Consider appropriateness of rivaroxiban ISO morbid obesity 
2) Titration of torsemide for euvolemia
3) Consider addition of spironolactone for neurohumoral blockade 
ISO HFpEF
4) Dose reduced metoprolol ISO bradycardia to 50mg; titrate as 
indicated

#HCP: ___ (boyfriend)
cell: ___

>30 minutes spent coordinating discharge to rehab
 
Medications on Admission:
The Preadmission Medication list is accurate and complete.
1. Acetaminophen 650 mg PO Q8H:PRN Pain - Mild 
2. Gabapentin 300 mg PO TID 
3. Metoprolol Succinate XL 100 mg PO DAILY 
4. Amiodarone 200 mg PO DAILY 
5. Rivaroxaban 20 mg PO DAILY 
6. Ranitidine 300 mg PO QHS 
7. Atorvastatin 40 mg PO QPM 
8. Torsemide 80 mg PO DAILY 
9. dexlansoprazole 60 mg oral DAILY 
10. albuterol sulfate 90 mcg/actuation inhalation Q4H:PRN 
11. Levalbuterol Neb 0.63 mg NEB Q6H:PRN wheezing 
12. Pantoprazole 40 mg PO Q12H 

 
Discharge Medications:
1.  Aluminum-Magnesium Hydrox.-Simethicone ___ mL PO TID:PRN 
reflux  
2.  Benzonatate 100 mg PO TID cough  
3.  Capsaicin 0.025% 1 Appl TP Q8H:PRN leg pain  
4.  Cepacol (Sore Throat Lozenge) 1 LOZ PO Q2H:PRN sore throat  
5.  Dextromethorphan Polistirex ___ mg PO Q12H:PRN refractory 
cough  
6.  Guaifenesin-CODEINE Phosphate ___ mL PO Q6H:PRN cough 
RX *codeine-guaifenesin 10 mg-100 mg/5 mL 5 ml by mouth every 6 
hours as needed Refills:*0 
7.  Ipratropium Bromide Neb 1 NEB IH Q6H:PRN wheeze  
8.  Lidocaine 5% Ointment 1 Appl TP BID:PRN ___ pain  
9.  Miconazole Powder 2% 1 Appl TP TID:PRN  Erythema on skin 
folds on lower abdomen/GU region   
10.  QUEtiapine Fumarate 12.5 mg PO QHS  
11.  Metoprolol Succinate XL 50 mg PO DAILY  
12.  Torsemide 100 mg PO DAILY  
13.  Acetaminophen 650 mg PO Q8H:PRN Pain - Mild  
14.  albuterol sulfate 90 mcg/actuation inhalation Q4H:PRN  
15.  Amiodarone 200 mg PO DAILY  
16.  Atorvastatin 40 mg PO QPM  
17.  dexlansoprazole 60 mg oral DAILY  
18.  Gabapentin 300 mg PO TID  
19.  Levalbuterol Neb 0.63 mg NEB Q6H:PRN wheezing  
20.  Pantoprazole 40 mg PO Q12H  
21.  Ranitidine 300 mg PO QHS  
22.  Rivaroxaban 20 mg PO DAILY  

 
Discharge Disposition:
Extended Care
 
Facility:
___
 
Discharge Diagnosis:
Primary Diagnosis
Acute on Chronic Heart failure with preserved ejection fraction
Atypical Pneumonia
Sepsis

Secondary diagnosis
Steroid induced psychosis
Depression
Post traumatic stress disorder
Peripheral neuropathy
Atrial fibrillation
Anemia
OSA
GERD,Chronic inactive gastritis
Hyperglycemia
Yeast dermatitis
 
Discharge Condition:
Mental Status: Clear and coherent.
Level of Consciousness: Alert and interactive.
Activity Status: Ambulatory - Independent.

 
Discharge Instructions:
Dear Ms. ___,

It was a pleasure taking care of you at ___. Please see below 
for information on your time in the hospital.

================================
 WHY WAS I IN THE HOSPITAL?
================================
 - You came to the hospital because you were having shortness of 
breath, fevers, coughing with blood, and increased leg swelling.

================================
 WHAT HAPPENED IN THE HOSPITAL?
================================
 - You had an x ray that showed you likely had a pneumonia and 
were treated with antibiotics and steroids. To help with your 
cough symptoms, you received decongestants and cough 
suppressants. You required oxygen during the day, but this was 
slowly weaned off. Your fevers were treated with Tylenol, which 
gradually subsided. Your wheezing was treated with albuterol and 
ipratropium, and you required less throughout your stay. 
 - Your leg swelling improved with IV diuretics and your heart 
was closely monitored daily.
 - You were treated for your leg pain with your home gabapentin, 
Tylenol, as well as topical cream.
 - You were treated for your atrial fibrillation with your home 
amiodarone and metoprolol.
 - The redness underneath your skin folds were seen by the Wound 
Skin care team, and you were prescribed antifungals.
 - You were seen by Physical Therapy and Occupational Therapy to 
help with your body conditioning.
 - You received medication to help with your sleep and anxiety. 
You met with our Social work team.

================================
 WHAT SHOULD I DO WHEN I GO HOME?
================================
 - Please weigh yourself every morning. The weight you measure 
the very first morning after leaving the rehab should be your 
"baseline weight." If your weight is ever more than 3 lbs above 
or below this "baseline weight," please call your doctor for 
further instructions on what to do about your torsemide dosing 
that day. We believe your weight should generally be between 307 
and 312 lbs - if it is ever heavier than 312 lbs or less than 
307lbs you should call your cardiologist
 - Take your medications as listed below.
 - Follow up at the appointments listed below
 - Please call your doctor and/or present back to the ED if you 
are having concerning symptoms; a list of these symptoms is 
provided below.

We wish you the best!
 -Your Care Team at ___

 
Followup Instructions:
___


## Admissions [2152-11-18 18:07:00]
- Admission_Type: EW EMER.
- Admission_Location: PHYSICIAN REFERRAL
- Admission_Info: None

## Electronic Medicine Administration Record [2152-11-21 20:41:00]
| Medication | Event_Txt |
| ------ | ------ |
| Atorvastatin | Administered |
| Benzonatate | Administered |
| Docusate Sodium | Administered |
| Gabapentin | Administered |
| Potassium Chloride | nan |
| QUEtiapine Fumarate | Administered |
| Ranitidine | Administered |
| Ipratropium Bromide Neb | Administered |

## Provider Order Entry [2152-11-21 20:50:37]
- Order_Type: Medications
- Order_Subtype: nan

## Pharmacy [2152-11-21 20:51:48]
- Medication: Potassium Chloride
- Proc_Type: Unit Dose
- Status: Discontinued

## Electronic Medicine Administration Record [2152-11-21 20:53:00]
- Medication: Guaifenesin-CODEINE Phosphate
- Event_Txt: Administered

## Prescriptions [2152-11-21 21:00:00]
- Drug: Potassium Chloride
- Atc Type: nan
- Prod_Strength: 10mEq ER Tablet
- Dose_Val_Rx: 20
- Dose_Unit_Rx: mEq

## Electronic Medicine Administration Record [2152-11-21 21:10:00]
| Medication | Event_Txt |
| ------ | ------ |
| Levalbuterol Neb | Administered |
| Metoprolol Tartrate | Administered |
| Sodium Chloride 0.9%  Flush | Flushed |
| Potassium Chloride | Administered |
| Ipratropium Bromide Neb | Not Given |
| Levalbuterol Neb | Not Given |
| Furosemide | Confirmed |
| Levalbuterol Neb | Administered |
| Ipratropium Bromide Neb | Administered |
| Acetaminophen | Administered |
| Guaifenesin-CODEINE Phosphate | Administered |
| Lidocaine 5% Ointment | Administered |
| Metoprolol Tartrate | Administered |

## Labotary Test Events [2152-11-22 08:50:00]
| Item_Name | Valuenum | Valueuom | Ref_Range_Lower | Ref_Range_Upper | Flag | Comments |
| ------ | ------ | ------ | ------ | ------ | ------ | ------ |
| Anion Gap | 16.0 | mEq/L | 8.0 | 16.0 | nan | New calculation and Reference range as of ___. |
| Bicarbonate | 33.0 | mEq/L | 22.0 | 32.0 | abnormal | nan |
| Calcium, Total | 9.4 | mg/dL | 8.4 | 10.3 | nan | nan |
| Chloride | 97.0 | mEq/L | 96.0 | 108.0 | nan | nan |
| Creatinine | 1.1 | mg/dL | 0.4 | 1.1 | nan | nan |
| Ferritin | 37.0 | ng/mL | 13.0 | 150.0 | nan | nan |
| Glucose | 142.0 | mg/dL | 70.0 | 100.0 | abnormal | If fasting, 70-100 normal, >125 provisional diabetes. |
| H | 0.0 | nan | nan | nan | nan | nan |
| I | 1.0 | nan | nan | nan | nan | nan |
| Iron | 30.0 | ug/dL | 30.0 | 160.0 | nan | nan |
| Iron Binding Capacity, Total | 437.0 | ug/dL | 260.0 | 470.0 | nan | nan |
| Magnesium | 2.3 | mg/dL | 1.6 | 2.6 | nan | nan |
| Phosphate | 4.0 | mg/dL | 2.7 | 4.5 | nan | nan |
| Potassium | 3.8 | mEq/L | 3.3 | 5.1 | nan | nan |
| Sodium | 146.0 | mEq/L | 133.0 | 145.0 | abnormal | nan |
| Transferrin | 336.0 | mg/dL | 200.0 | 360.0 | nan | nan |
| Urea Nitrogen | 22.0 | mg/dL | 6.0 | 20.0 | abnormal | nan |
| L | 13.0 | nan | nan | nan | nan | nan |
| Hematocrit | 32.1 | % | 34.0 | 45.0 | abnormal | nan |
| Hemoglobin | 9.5 | g/dL | 11.2 | 15.7 | abnormal | nan |
| MCH | 24.1 | pg | 26.0 | 32.0 | abnormal | nan |
| MCHC | 29.6 | g/dL | 32.0 | 37.0 | abnormal | nan |
| MCV | 81.0 | fL | 82.0 | 98.0 | abnormal | nan |
| Platelet Count | 313.0 | K/uL | 150.0 | 400.0 | nan | nan |
| RDW | 17.2 | % | 10.5 | 15.5 | abnormal | nan |
| Red Blood Cells | 3.95 | m/uL | 3.9 | 5.2 | nan | nan |
| White Blood Cells | 10.3 | K/uL | 4.0 | 10.0 | abnormal | nan |
| RDW-SD | 50.2 | fL | 35.1 | 46.3 | abnormal | nan |

## Electronic Medicine Administration Record [2152-11-22 08:57:00]
| Medication | Event_Txt |
| ------ | ------ |
| Amiodarone | Administered |
| Benzonatate | Administered |
| Docusate Sodium | Administered |
| Gabapentin | Administered |
| Pantoprazole | Administered |
| Sodium Chloride 0.9%  Flush | Flushed |
| Furosemide | Confirmed |

## Provider Order Entry [2152-11-22 09:29:40]
| Order_Type | Order_Subtype |
| ------ | ------ |
| Lab | nan |
| Lab | nan |
| Medications | nan |

## Pharmacy [2152-11-22 10:48:51]
- Medication: Potassium Chloride
- Proc_Type: Unit Dose
- Status: Discontinued

## Prescriptions [2152-11-22 11:00:00]
- Drug: Potassium Chloride
- Atc Type: nan
- Prod_Strength: 10mEq ER Tablet
- Dose_Val_Rx: 20
- Dose_Unit_Rx: mEq

## Electronic Medicine Administration Record [2152-11-22 11:38:00]
| Medication | Event_Txt |
| ------ | ------ |
| Ipratropium Bromide Neb | Administered |
| Metoprolol Tartrate | Administered |
| Potassium Chloride | Administered |

## Provider Order Entry [2152-11-22 13:15:15]
| Order_Type | Order_Subtype |
| ------ | ------ |
| Lab | nan |
| Lab | nan |

## Electronic Medicine Administration Record [2152-11-22 13:45:00]
- Medication: Levalbuterol Neb
- Event_Txt: Administered

## Provider Order Entry [2152-11-22 14:11:29]
| Order_Type | Order_Subtype |
| ------ | ------ |
| General Care | Telemetry |
| General Care | Tubes/Drains |

## Electronic Medicine Administration Record [2152-11-22 14:15:00]
| Medication | Event_Txt |
| ------ | ------ |
| Benzonatate | Administered |
| Acetaminophen | Administered |
| Guaifenesin-CODEINE Phosphate | Administered |
| Gabapentin | Administered |

## Labotary Test Events [2152-11-22 14:58:00]
| Item_Name | Valuenum | Valueuom | Ref_Range_Lower | Ref_Range_Upper | Flag | Comments |
| ------ | ------ | ------ | ------ | ------ | ------ | ------ |
| Anion Gap | 13.0 | mEq/L | 8.0 | 16.0 | nan | New calculation and Reference range as of ___. |
| Bicarbonate | 33.0 | mEq/L | 22.0 | 32.0 | abnormal | nan |
| Calcium, Total | 9.3 | mg/dL | 8.4 | 10.3 | nan | nan |
| Chloride | 95.0 | mEq/L | 96.0 | 108.0 | abnormal | nan |
| Creatinine | 1.2 | mg/dL | 0.4 | 1.1 | abnormal | nan |
| Glucose | 226.0 | mg/dL | 70.0 | 100.0 | abnormal | If fasting, 70-100 normal, >125 provisional diabetes. |
| H | 4.0 | nan | nan | nan | nan | nan |
| I | 1.0 | nan | nan | nan | nan | nan |
| Magnesium | 2.3 | mg/dL | 1.6 | 2.6 | nan | nan |
| Phosphate | 3.8 | mg/dL | 2.7 | 4.5 | nan | nan |
| Potassium | 3.9 | mEq/L | 3.3 | 5.1 | nan | nan |
| Sodium | 141.0 | mEq/L | 133.0 | 145.0 | nan | nan |
| Urea Nitrogen | 24.0 | mg/dL | 6.0 | 20.0 | abnormal | nan |
| L | 11.0 | nan | nan | nan | nan | nan |

## Electronic Medicine Administration Record [2152-11-22 16:12:00]
| Medication | Event_Txt |
| ------ | ------ |
| Furosemide | Confirmed |
| Pantoprazole | Administered |
| Rivaroxaban | Administered |
| Sodium Chloride 0.9%  Flush | Flushed |
| Ipratropium Bromide Neb | Administered |
| Levalbuterol Neb | Administered |
| Metoprolol Tartrate | Administered |
| Guaifenesin-CODEINE Phosphate | Administered |
| Docusate Sodium | Administered |
| Benzonatate | Administered |
| Gabapentin | Administered |
| Atorvastatin | Administered |
| QUEtiapine Fumarate | Administered |
| Ranitidine | Administered |

## Provider Order Entry [2152-11-22 19:43:20]
- Order_Type: Medications
- Order_Subtype: nan

## Pharmacy [2152-11-22 19:46:07]
- Medication: Potassium Chloride
- Proc_Type: Unit Dose
- Status: Discontinued
</patient_timeline>

<candidate_answers>
["Potassium Chloride (Powder)", "Insulin (Regular) for Hyperkalemia", "Caltrate", "Klor-Con 8", "Potassium Acetate", "Copper Chloride", "Potassium Chloride (Klor-conM10)", "Potassium Phosphate", "Sodium Chloride 23.4%", "Potassium Chl 40 mEq / 1000 mL D5NS", "KePPRA", "Kcentra*", "Potassium Chloride", "Potassium Chloride (Po 20mEq PKT", "magnesium chloride", "potassium citrate", "Potassium Chl 20 mEq / 1000 mL D5W", "Sodium Chloride  (Mini Bag Plus)", "Potassium Chl 40 mEq / 1000 mL NS", "Sodium Chloride 5 %", "Iso-Osmotic Sodium Chloride", "Potassium Ch", "Klor-Con", "Alum Potassium", "Micro-K", "Potassium Chloride Oral Sol", "sodium chlor", "Zinc Chloride", "Sodium Chloride", "urea", "Saline", "Phosphorus", "Urea", "ethyl chloride", "Calcium Gluconate", "Polyethylene Glycol", "KlonoPIN", "Potassium Chl 20 mEq / 1000 mL NS", "potassium citrate ER", "23.4% Sodium Chloride", "Ket", "Potassium Chl 20 mEq / 1000 mL D5NS", "0.9% Sodium Chloride", "Ethyl Chloride", "potassium ch", "potassium gluconate", "aluminum chloride", "Chlorthali", "Klor-Con 10", "Klonopin", "Potassium Iodide", "Sodium", "sodium bicarb-sodium chloride", "Keflex", "Potassium Chloride Oral Soln", "Keppra", "potassium", "Potassium Chl 20 mEq / 1000 mL D5LR", "0.9 % Sodium Chloride", "Potassium Chl 40 mEq / 1000 mL D5W", "Calcium Chloride", "keppra", "Potassium Citrate", "Potassium Chloride 10meq Capsules", "Hydrochloric Acid", "0.83% Sodium Chloride", "potassium chloride ER", "Sodium Chloride 7%", "Potassium Chloride Replacement (Oncology)", "Mineral", "calcium gluconate", "Sodium Phosphate", "Ketorola", "Chloral hydrate", "PlasmaLyte", "potassium chloride", "potassium citrate tablets", "Balanced Salt Opth. Soln", "Potassium Chloride Replacement (Critical Care and Oncology)", "sodium chloride", "Potassium Bicarbonate Eff", "Potassium Chloride 10mEq TAB", "Solution", "Sodium Chloride 0.9% (P.F.)", "Potassium Chl 20 mEq / 1000 mL D5 1/2 NS", "Potassium Chl 40 mEq / 1000 mL D5 1/2 NS", "Potassium C 20mEq/50mL 50mL IVPB", "chlorh", "Keppra *Brand Name*", "Creatinine (Bulk)", "Potassium 10mEq/100mL 100mL IVPB", "Potassium", "chloral hydrate", "Kcentra", "Isotonic Sodium Chloride", "Urocit-K 10", "sodium", "potassium chlo", "Keppra BRAND NAME", "Potassium Chl", "Chloral Hydrate"]
</candidate_answers>

---
After any reasoning, emit your final answer inside an <answer>...</answer> XML block as the very last thing you write. Put one answer per line inside the block, with no bullets, numbering, or markdown. If the task expects a single polar answer, put just that one line. If <candidate_answers> were provided, each line must match a candidate verbatim.
```

### One-shot final assistant reasoning

> Looking at the patient timeline, I need to analyze what medication would be most appropriate to prescribe next.
> 
> Key observations from the timeline:
> 1. The patient has been receiving **Potassium Chloride** multiple times - it was prescribed on 2152-11-21 21:00:00 and again on 2152-11-22 11:00:00
> 2. The latest event at 2152-11-22 19:46:07 shows **Potassium Chloride was discontinued** by Pharmacy
> 3. The patient is on **Furosemide** (a loop diuretic that causes potassium wasting) - confirmed at 08:57 and 16:12 on 11/22
> 4. Recent labs on 11/22 show:
>    - Potassium: 3.8 mEq/L (morning) and 3.9 mEq/…
